AQSCIR ?'G' in Pharmaceutical R&D


By: Meenakshi L -- Senior Research Analyst

27 June, 2014

AQSCIR ?'G' in Pharmaceutical R&D

Procurement decisions are no longer limited to cost savings, quality and time; sustainability is the new addition to procurement decision making. Risks arising from environmental and social factors, compliance, value creation and external demand are driving sustainable procurement. Upcoming green cap regulations can put pressure on sourcing of all commodities and services including clinical trials. This makes it pertinent for R&D procurement groups to evaluate carbon intensity along clinical trial supply chain and adopt mitigation strategies


COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)